ACE inhibitors in renal disease

Area of Science:

• Nephrology
• Cardiovascular Research
• Pharmacology

Background:

• Essential hypertension can lead to hemodynamically mediated glomerular injury.
• The preglomerular and postglomerular arterioles' resistance state may influence kidney protection by antihypertensive agents.

Purpose of the Study:

• To review the effects of angiotensin II on renal microcirculation.
• To discuss the pathophysiology of essential hypertensive renal disease.
• To examine the renal pharmacology of angiotensin-converting enzyme (ACE) inhibitors.
• To explore the hypothesis linking renal protection to control of systemic and glomerular hypertension.

Main Methods:

• Literature review of experimental studies and existing research.
• Synthesis of information on angiotensin II, hypertensive renal disease, and ACE inhibitors.
• Analysis of the proposed hypothesis regarding blood pressure control and renal protection.

Main Results:

• Angiotensin II significantly impacts renal microcirculation.
• Understanding hypertensive renal disease pathophysiology is crucial.
• ACE inhibitors offer a specific pharmacological approach to renal protection.
• Evidence suggests a strong correlation between blood pressure control and kidney health.

Conclusions:

• The resistance of renal arterioles is a critical factor in antihypertensive drug efficacy for kidney protection.
• Controlling both systemic and glomerular hypertension is hypothesized to be essential for preventing hemodynamically mediated glomerular injury.
• Further research into the mechanisms of ACE inhibitors and their impact on renal hemodynamics is warranted.